Targeted therapy of Schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin
- 26 September 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 73 (1), 117-124
- https://doi.org/10.1002/(sici)1097-0215(19970926)73:1<117::aid-ijc18>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Intra-tumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effectsInternational Journal of Cancer, 1997
- Schannoma cells induce a tumor-cell-specific cytotoxic- T-cell response upon transplantation into syngeneic rats but escape elimination through the secretion of immunosuppressive factorsInternational Journal of Cancer, 1997
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.Journal of Clinical Oncology, 1996
- In Vivo Efficacy of Intrathecal Transferrin-Pseudomonas Exotoxin A Immunotoxin against LOX MelanomaNeurosurgery, 1994
- The epidermal growth factor receptor as a target for therapy in breast carcinomaBreast Cancer Research and Treatment, 1994
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.JCI Insight, 1993
- Prevalence of aberrant expression of the epidermal growth factor receptor in human cancersBritish Medical Bulletin, 1991
- Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coliCell, 1987
- Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.Proceedings of the National Academy of Sciences, 1986
- [16] Plasmids of Escherichia coli as cloning vectorsMethods in enzymology, 1979